Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,308 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,308 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,308 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,308 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,308 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,308 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,308 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
8 Jan 2026
Mark S. Garfield Chief Accounting Officer
Sold on a plan
$199.71K 953 at 209.56
2.6%
Planned (10b5-1)
8 Jan 2026
Matthew B. Klein Chief Executive Officer
Sold on a plan
$192.20K 2,514 at 76.45
0.6%
Planned (10b5-1)
8 Jan 2026
Amit Dhingra Chief Enterprise Pmts Officer
Sold on a plan
$185.00K 10,000 at 18.50
6.0%
Planned (10b5-1)
8 Jan 2026
Michael Alexander Smith Chief Legal Officer
Sold at will
$183.40K 1,053 at 174.17
1.8%
Not planned
8 Jan 2026
John C Watts EVP & Chief Growth Officer
Sold on a plan
$172.80K 288 at 600.00
8.3%
Planned (10b5-1)
8 Jan 2026
Jesse Timmermans Chief Financial Officer
Sold on a plan
$168.55K 5,349 at 31.51
31.5%
Planned (10b5-1)
8 Jan 2026
Hongyu Zhou Director
Bought
$168.31K 139,097 at 1.21
39.5%
Largest buy in 3 yrs
8 Jan 2026
Bought
$163.65K 13,683 at 11.96
0.2%
8 Jan 2026
Paul F. Lizzul Chief Medical Officer
Sold at will
$163.19K 3,650 at 44.71
8.0%
Not planned
8 Jan 2026
Saba Capital Management, L.P. 10% owner · indirect
Bought
$150.50K 2,479 at 60.71
0.0%
8 Jan 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer
Sold on a plan
$150.01K 5,000 at 30.00
7.5%
Planned (10b5-1)
8 Jan 2026
Chaim Indig Chief Executive Officer
Sold at will
$143.54K 8,440 at 17.01
0.6%
Not planned
8 Jan 2026
Balaji Gandhi Chief Financial Officer
Sold at will
$136.21K 8,009 at 17.01
4.9%
Not planned
8 Jan 2026
Ali Kashani Chief Executive Officer
Sold at will
$129.96K 9,088 at 14.30
0.3%
Not planned
8 Jan 2026
Jacob DeWitte Co-Founder, CEO also filed by Caroline Cochran
Sold on a plan
$125.50K 1,255 at 100.00
0.2%
Planned (10b5-1)
8 Jan 2026
Kevin McCulloch See Remarks
Sold on a plan
$120.00K 15,000 at 8.00
0.9%
Planned (10b5-1)
8 Jan 2026
Adam B Frankel General Counsel
Sold on a plan
$119.57K 4,382 at 27.29
2.0%
Planned (10b5-1)
8 Jan 2026
Tara D Mackey Chief Legal Officer
Sold at will
$118.71K 1,000 at 118.71
3.3%
Not planned
8 Jan 2026
Timothy Price Crain II SVP and Chief Growth Officer
Sold on a plan
$113.22K 5,660 at 20.00
1.9%
Planned (10b5-1)
8 Jan 2026
Dennis Mulroy Chief Financial Officer
Sold at will
$112.45K 2,515 at 44.71
10.3%
Not planned
8 Jan 2026
Allison C Hoffman General Counsel & Secretary
Sold at will
$111.99K 6,585 at 17.01
3.6%
Not planned
8 Jan 2026
James Labe Chief Executive Officer · indirect also filed by Sajal Srivastava
Bought on a plan
$111.20K 16,833 at 6.61
0.9%
Bought on a plan
8 Jan 2026
Evan Roberts President, Provider Solutions
Sold at will
$107.43K 6,317 at 17.01
0.8%
Not planned
8 Jan 2026
David Linetsky President, Network Solutions
Sold at will
$103.85K 6,106 at 17.01
2.6%
Not planned
8 Jan 2026
Eric J Loumeau Chief Legal Officer
Sold at will
$98.81K 2,210 at 44.71
14.7%
Not planned
8 Jan 2026
Joseph Oliveto President and CEO
Sold on a plan
$96.75K 43,000 at 2.25
12.4%
Planned (10b5-1)
8 Jan 2026
Christopher Schmitt General Counsel and Secretary
Sold on a plan
$88.21K 4,507 at 19.57
0.4%
Planned (10b5-1)
8 Jan 2026
Chandrasekar Gnanasambandam EVP Product & CTO
Sold on a plan
$83.08K 4,245 at 19.57
0.8%
Planned (10b5-1)
8 Jan 2026
Grigorios Siokas Chief Executive Officer
Bought
$81.00K 156,190 at 0.52
2.2%
8 Jan 2026
Christine Marie Utter SVP, Chief Accounting Officer
Sold on a plan
$79.05K 1,034 at 76.45
1.4%
Planned (10b5-1)
8 Jan 2026
William Chou President and CEO
Sold at will
$75.16K 4,076 at 18.44
38.5%
Not planned
8 Jan 2026
Brian Read Chief Financial Officer
Sold on a plan 2×
$75.05K 4,748 at 15.81
1.4%
Planned (10b5-1)
8 Jan 2026
Mitra Rezvan Chief Accounting Officer
Sold on a plan
$74.02K 3,782 at 19.57
3.1%
Planned (10b5-1)
8 Jan 2026
Bought
$71.08K 3,240 at 21.94
0.0%
8 Jan 2026
Abby Payne Chief People Officer
Sold on a plan
$70.10K 3,582 at 19.57
0.5%
Planned (10b5-1)
8 Jan 2026
Neil Gregory Almstead Chief Technical Ops Officer
Sold on a plan
$67.35K 881 at 76.45
0.8%
Planned (10b5-1)
8 Jan 2026
Derek M Meisner Chief Legal Officer & Corp Sec
Sold at will 2×
$67.25K 36,911 at 1.82
27.5%
Not planned
8 Jan 2026
Lee Scott Golden EVP & Chief Medical Officer
Sold on a plan
$66.21K 866 at 76.45
0.9%
Planned (10b5-1)
8 Jan 2026
Scott S Slater Director
Bought
$64.25K 5,000 at 12.85
8.4%
Largest buy in 3 yrs
8 Jan 2026
Touraj Parang President & COO
Sold at will
$57.31K 4,008 at 14.30
0.3%
Not planned
8 Jan 2026
Raphael Bousquet Chief Revenue Offucer
Sold at will
$54.73K 3,224 at 16.97
100%
Sold half or more
8 Jan 2026
Matthew Rizik Director
Sold on a plan
$53.21K 2,500 at 21.29
0.2%
Planned (10b5-1)
8 Jan 2026
Amy Beth VanDuyn SVP, Human Resources
Sold at will
$44.25K 2,602 at 17.01
1.6%
Not planned
8 Jan 2026
Matthijs Glastra Chief Executive Officer
Sold on a plan
$42.04K 323 at 130.14
0.4%
Planned (10b5-1)
8 Jan 2026
Sold at will
$38.02K 2,062 at 18.44
27.6%
Not planned
8 Jan 2026
Alan Rappaport Director
Bought
$37.95K 2,000 at 18.97
200%
First buy on file
8 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$34.95K 13,000 at 2.69
100%
Sold half or more
8 Jan 2026
Randy Soule 10% owner · indirect
Sold at will
$34.26K 200,000 at 0.17
0.3%
Not planned
Showing 49,301–49,350 of 60,308. ← Newer Page 987 of 1,207 Older →